At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 18 enrolled
Drug / intervention
Radiofrequency ablationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation
In Brief
A Phase 3 clinical trial evaluating Radiofrequency ablation for Adrenal Tumors. Completed, enrolled 18 participants across 2 sites.
Detailed Summary
The purpose of this study is to evaluate changes in adrenal hormones during adrenal radiofrequency (RF) ablation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAdrenal Tumors
CountriesJapan
Collaborators--
Timeline
Phase 3CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2009
First PostedOct 2009
Primary CompletionOct 2010
TodayJul 2026
First PostedOct 19, 2009
Enrollment StartOct 1, 2009
Primary CompletionOct 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 16.7 years ago
Interventions
Radiofrequency ablationprocedure
Radiofrequency (RF) ablation was done after RF electrodes were placed in the adrenal tumor in the adrenal RF ablation group. RF ablation was done after RF electrodes were placed in the targeted abdominal tumors other than adrenal gland in the abdominal RF ablation other than adrenal gland group.